Bristol-Myers Squibb and Otsuka Pharmaceuticals have launched ari-piprazole orally disintegrating tablets (Discmelt). The tablets are are bioequivalent to the antipsychotic medication Abilify. Discmelt was approved on June 7, 2006.
The tablets offer a convenient alternative for adults with schizophrenia or manic episodes associated with Bipolar I Disorder. They disintegrate rapidly upon contact with saliva. No liquids are needed.
buy antibiotics canada
The vanilla-flavored 10- and 15-mg tablets are available in blister packs.
Adults with phenylketonuria should be advised that this product contains phenylalanine. A boxed warning states that Discmelt is not approved for patients with dementia-related psychosis.